MBGPF

MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)

About MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)

Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

Details

Daily high
$0.99
Daily low
$0.99
Price at open
$0.99
52 Week High
$1.14
52 Week Low
$0.69
Market cap
46.4M
Dividend yield
0.00%
Volume
1,000
Avg. volume
1,398
P/E ratio
-1.92

MOBERG PHARMA AB by MOBERG PHARMA AB News

Details

Daily high
$0.99
Daily low
$0.99
Price at open
$0.99
52 Week High
$1.14
52 Week Low
$0.69
Market cap
46.4M
Dividend yield
0.00%
Volume
1,000
Avg. volume
1,398
P/E ratio
-1.92